Subscribe
shutterstock_1397823587_pavel_kapysh
Pavel Kapysh / Shutterstock.com
21 December 2021AmericasAlex Baldwin

BioDelivery Sciences ‘pleased’ with mixed ruling over Opioid drug claims

A Delaware Federal Court has upheld some of the validity of challenged claims in two patents related to BioDelivery Sciences’ (BDSI) opioid medication Belbuca (buprenorphine), but invalidated others.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Monosol sues BioDelivery over pain treatment
17 January 2017   Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement.
Americas
Teva sued over opioid overdose drug
25 October 2016   Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Monosol sues BioDelivery over pain treatment
17 January 2017   Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement.
Americas
Teva sued over opioid overdose drug
25 October 2016   Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan.

More on this story

Americas
Monosol sues BioDelivery over pain treatment
17 January 2017   Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement.
Americas
Teva sued over opioid overdose drug
25 October 2016   Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility